SPRING1
SREBP regulating gene protein
Also known as: C12orf49, FLJ21415, LUR1, POST1, SPRING, SPRNG_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9H741
- Gene
- SPRING1
- Ensembl
- ENSG00000111412
- Chromosome
- 12
- Canonical length
- 205 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
Involved in positive regulation of SREBP signaling pathway. Located in Golgi membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
205 residues, UniProt reviewed canonical sequence.
>Q9H741|SPRING1
1 MVNLAAMVWR RLLRKRWVLA LVFGLSLVYF LSSTFKQEER AVRDRNLLQV HDHNQPIPWK
61 VQFNLGNSSR PSNQCRNSIQ GKHLITDELG YVCERKDLLV NGCCNVNVPS TKQYCCDGCW
121 PNGCCSAYEY CVSCCLQPNK QLLLERFLNR AAVAFQNLFM AVEDHFELCL AKCRTSSQSV
181 QHENTYRDPI AKYCYGESPP ELFPALocalizationUniProt · AlphaFold · HPA
Whether an antibody against SPRING1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.38
- Highest tissue expression
- 35 nTPM
Expression across tissuesHPA
Tissue
- thyroid gland: 35 nTPM
- lung: 17 nTPM
- choroid plexus: 17 nTPM
- kidney: 16 nTPM
- salivary gland: 13 nTPM
- cerebral cortex: 12 nTPM
Single-cell type
- alveolar cells type 1: 214 nCPM
- endometrial glandular cells: 132 nCPM
- parietal cells: 131 nCPM
- alveolar cells type 2: 96 nCPM
- epididymal efferent duct ciliated cells: 84 nCPM
- transitional alveolar cells: 82 nCPM
Immune cell
- memory B-cell: 5.7 nTPM
- naive B-cell: 4.9 nTPM
- MAIT T-cell: 4.6 nTPM
- gdT-cell: 4.5 nTPM
- plasmacytoid DC: 4.3 nTPM
- eosinophil: 4.1 nTPM
Brain region
- thalamus: 38 nTPM
- medulla oblongata: 37 nTPM
- hypothalamus: 35 nTPM
- midbrain: 33 nTPM
- pons: 33 nTPM
- basal ganglia: 29 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.03
- gnomAD pLI
- 0.01
- DepMap mean gene effect
- -0.13
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
- SREBP regulating gene protein
- SREBP regulating gene protein
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SPRING1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SPRING1 as an antibody target. Whether an autoantibody or antibody against SPRING1 could matter depends on whether native SPRING1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SPRING1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SPRING1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...